Interim Recommendations for Use of Bivalent mRNA COVID-19 Vaccines for Persons Aged [greater than or equal to]6 Months--United States, April 2023

Authors :: Moulia, Danielle L.
Wallace, Megan
Roper, Lauren E.
Godfrey, Monica
Rosenblum, Hannah G.
Link-Gelles, Ruth
Britton, Amadea
Daley, Matthew F.
Meyer, Sarah
Fleming-Dutra, Katherine E.
Oliver, Sara E.
Twentyman, Evelyn
Source :: Morbidity and Mortality Weekly Report. June 16, 2023, Vol. 72 Issue 24, p657, 6 p.
Publication Year :: 2023
Abstract: Throughout the national public health emergency declared in response to the COVID-19 pandemic, CDC, guided by the Advisory Committee on Immunization Practices (ACIP), has offered evidence-based recommendations for the use [...]

Subjects :: United States. Food and Drug Administration
Pfizer Inc.
Messenger RNA -- Usage
Public health -- Usage
Vaccines -- Usage
Evidence-based medicine -- Usage
Pharmaceutical industry -- Usage
Health

Tools